Background: The choice of sampling techniques in bronchoscopy with sampling from a visible lesion will depend on the expected diagnostic yields and the costs of the sampling techniques. Aims: The aim of this study was to determine the most economical combination of sampling techniques when approaching endobronchial visible lesions. Methods: A cost minimization analysis was performed. All bronchoscopies from 2003 and 2004 at Haukeland university hospital, Bergen, Norway, were reviewed retrospectively for diagnostic yields. 162 patients with endobronchial disease were included. Potential sampling techniques used were biopsy, brushing, endobronchial needle aspiration (EBNA) and washings. Costs were estimated based on registration of equipment costs and personnel costs. Sensitivity analyses were performed to determine threshold values. Results: The combination of biopsy, brushing and EBNA was the most economical strategy with an average cost of Euro 893 (95% CI: 657, 1336). The cost of brushing had to be below Euro 83 and it had to increase the diagnostic yield more than 2.2%, for biopsy and brushing to be more economical than biopsy alone. The combination of biopsy, brushing and EBNA was more economical than biopsy and brushing when the cost of EBNA was below Euro 205 and the increase in diagnostic yield was above 5.2%. Conclusion: In the current study setting, biopsy, brushing and EBNA was the most economical combination of sampling techniques for endobronchial visible lesions. 
Introduction
Bronchoscopy is the main diagnostic method for endobronchial visible lesions. 1e3 A biopsy allows for a histological sample, which inherently has more information than a cytological sample. However, in many instances, a cytological sample can be sufficient for the establishment of a malignant diagnosis in the airways, and most physicians will prefer to take cytological samples in addition to biopsies when encountering an endobronchial lesion. The choices for cytological sampling are brushing, endobronchial needle aspiration (EBNA), and washings. The optimal combination of all sampling techniques is still debated, due to differences in yield and cost.
The previous recommended combinations have been biopsy, brushing and washing, 4e7 biopsy and brushing, 8e10 biopsy, brushing or washing, 11, 12 biopsy, brushing and EBNA, 13e15 or EBNA alone with rapid on-site cytological evaluation (ROSE) combined with supplemental techniques if negative. 16 So far, the diagnostic yield has been the most important criterion for the recommendations. However, the costs of the different sampling techniques vary greatly, and the overall cost of the procedure will in a large part be dependent on how each center organizes its diagnostic procedures. The main weakness of the current recommendations is the lack of data on true costs. Although some studies of bronchial washings have included costs, 11, 12 the most economical combination of all sampling techniques has yet not been settled.
The aim of this study was to determine the most economical combination of sampling techniques in bronchoscopy of endobronchial visible lesions, using a cost minimization analysis.
Methods

Study design
The bronchoscopies included in the current study were performed in 2003 and 2004 at Haukeland University Hospital, Bergen, Norway. Haukeland University Hospital is responsible for the diagnosis and treatment of lung cancer in a geographical area comprising 380 000 inhabitants, and serves as a referral center for surrounding smaller hospitals comprising 950 000 inhabitants. Most patients examined on suspicion of lung cancer are admitted to a day ward at the hospital.
A total of 1438 bronchoscopies were performed in 2003 and 2004, of which 551 were performed on suspicion of malignant disease. The sampling and execution of these investigations, with their diagnostic yields, have been published previously. 17 For the current study, all 162 patients with an endobronchial visible lesion deemed suspicious of malignancy upon inspection were included. The bronchoscopies were performed by 22 different physicians.
Sample collection
The investigations were performed with Olympus BF 1T 160 bronchoscopes, using Boston ''Radial Jaw3'' for biopsies, Boston 21 Gauche ''Stifcor'' transbronchial aspiration needle for EBNA, and Boston ''Cellebrity'' for brushings.
EBNA was taken directly from the endobronchial lesions. Washings were performed with aspiration of fluid from the entire procedure and a sample of the fluid was sent to the pathological department for investigation. In some cases small volume lavage (SVL) was performed. However, SVL was too seldom performed to warrant inclusion in the current analyses. The physicians determined which sample techniques to employ, and in which order, during the bronchoscopies. Thus, not all patients had all possible sample techniques performed, and the order may vary.
Costs
All costs were transformed to the 2004 NOK value according to the Consumer Price Index in Norway and transformed to Euro with the interbank rate of 8.39760 on 01.01.2004.
All available costs for equipment in the department of thoracic medicine and the department of pathology were included. The average equipment cost of the bronchoscope and its cleaning were based on an average of 715 investigations yearly and an average duration of bronchoscopes of 7 years and average duration time for the washing machine of 10 years.
To estimate the time cost of physicians and nurses in the bronchoscopy lab, the time consumption of all present personnel was registered in detail for 24 bronchoscopies. The personnel costs were calculated based on the median value for time, the average number of personnel present, and the average wages per personnel category. The estimates were compared with registration of personnel use in a larger prospective register in our bronchoscopy lab, and found to be representative.
The estimation of the personnel cost for examining biopsies at the department of pathology was based on a detailed registration of 25 examined samples by the pathologist. The time consumption in the cytopathology lab was based on 11 detailed registrations and expert opinion that assumed that the average time consumption for the pathology technician was 5 min for preparation of all slides, and 4 min for investigation of each slide. The time consumption was based on an average number of slides examined per sampling technique for the bronchoscopies performed in 2004.
The average cost of a stay at the day ward was estimated by the average diagnosis related group (DRG) refund divided by the average days spent in the day ward for patients admitted in 2007 and adjusted to 2004 value. The results of the bronchoscopy samplings were presented by the pathologists at an interdisciplinary meeting every Friday. The cost of a false negative sample was assumed to be another five days in the day ward plus the cost of a repeated bronchoscopy.
Cost minimization analysis
A cost effectiveness analysis compares how the increase in costs of a new clinical strategy compares with the existing strategy. If the average cost for increased effectiveness is below the willingness to pay, the new strategy is cost effective. Usually the effectiveness is measured in quality adjusted life years (QALY). However, it is difficult to measure a difference in QALY based on the results of bronchoscopy.
The cost minimization analysis assumes that the competing strategies have equivalent outcomes, 18 and that the strategy with the lowest costs is most economical. If a diagnosis is not reached based on a result from the bronchoscopy, the standard procedure is to perform a repeated bronchoscopy. In this study we assumed that a final diagnosis of visible lesions would be reached in a maximum of three repeated bronchoscopies. The diagnostic yield of a repeated bronchoscopy was assumed to be in the same range as the first bronchoscopy. Further, for the purpose of the cost minimization analyses, we assumed that the second and third bronchoscopy was performed with the same combination of sampling techniques as in the first bronchoscopy. The decision tree is displayed in Fig. 1 . The diagnostic yield in the decision tree was based on the average diagnostic yield for both malignant and benign lesions. Five actual strategies were included in the analysis. Biopsy was included in all strategies based on a high diagnostic yield compared to costs. Washing was only included in the strategy with all sampling techniques due to a low diagnostic yield.
In the model the uncertainty of the costs was modeled with a beta distribution with the tails three standard deviations from the mean. 30% deviation represented three standard deviations. 19 Since the aim of this study was to compare differences in costs between different sampling techniques, costs that were the same for all strategies were not included in the analysis, like the costs of blood samples and lung function tests and the costs for a stay in the day ward for the first bronchoscopy.
Sensitivity analyses were performed to find threshold values. Threshold values represent the values that will change the most economical strategy. In one way sensitivity analyses all variables are constant except the actual variable that is analyzed. By increasing or decreasing the value of the variable being analyzed, the threshold value will appear when there is a change in which strategy that is most economical.
Statistical analysis
All effectiveness data were analyzed in SPSS version 13. 20 The cost minimization analysis was performed in TreeAge Pro Health Care 2007. 21 The confidence intervals were calculated with Monte Carlo simulations with 1000 simulations. The threshold values for different strategies were found by rebuilding the decision tree with two branches.
The Regional Norwegian Ethical Committee and the Norwegian Social Science Data Service approved the study. 
Results
Of the 162 patients in the study, 64 were women. Malignant disease was diagnosed in 154 patients, of which 36 (23.4%) had small cell lung cancer, 98 (63.6%) non-small cell lung cancer (14 adenocarcinoma, 44 squamous cell carcinoma and 40 other non-small cell carcinoma). Five (3.2%) of the patients had a carcinoid tumor, seven (4.5%) had lung metastases and three (1.9%) had lymphoma. Five patients had a final malignant diagnosis based on follow-up. Of the eight patients with benign disease, one patient had a granulation polyp, one patient had oropharyngeal cancer but samples from the lung did not show malignancy, one patient had a polyp with squamous cell metaplasia, four patients had lesions suspicious of malignancy but proven benign at follow-up, and one patient had a benign lesion below the vocal cords.
The average costs of a stay for one day at the day ward, a bronchoscopy and for each sampling technique are displayed in Table 1 . EBNA was the most expensive sampling technique; more than three times as expensive as a biopsy, and almost nine times as expensive as washings.
The time consumption for the different employees and their average wages are shown in Table 2 . In 90% of the procedures, an additional junior physician was present, while for all procedures, an average of 2.1 nurses was present, irrespective of combination of sampling techniques. Table 3 presents the diagnostic yield from the combination of sampling techniques employed in each of the five strategies. Note that among the 162 patients, biopsy was taken in 132 patients, brushing in 66, EBNA in 116, and washing in 158. Biopsy had sensitivity for cancer of 78.7% (Table 3) . None of the benign cases were definitely diagnosed by bronchoscopy. Thus, the overall diagnostic yield for biopsy was 75.8% for benign and malignant disease combined. Brushing increased the overall diagnostic yield to 78.8%. Biopsy, brushing and EBNA had an overall diagnostic yield of 86.0%. Washing did not increase the diagnostic yield when biopsy, brushing and EBNA was performed (Table 3) .
Based on the total costs and diagnostic yields for each strategy, the median cost was found to be Euro 893 (95% CI: 621, 1336) for biopsy, brushing and EBNA, compared to Euro 970 (637, 1471) for biopsy and brushing, and Euro 999 (751, 1331) for biopsy alone (Table 4) .
Sensitivity analysis
The threshold values for one way sensitivity analysis are shown in Table 5 . The combination of brushing and biopsy was dependent on an overall diagnostic yield for benign and malignant disease of minimum 78.0% or a cost of brushings below Euro 83 to be more economical than biopsy alone. If the diagnostic yield of biopsy, brushing and EBNA was above 84.0%, or the cost of EBNA was below Euro 205 the triple combination was more economical than biopsy and brushing. When the average cost of the stay in the day ward was below Euro 189, biopsy alone was most economical, between Euro 189 and Euro 311 biopsy and brushing was more economical, above Euro 311 biopsy, brushing and EBNA was most economical, based on the assumption that a missed diagnosis would increase the cost with five days in day ward. Biopsy, brushing and EBNA was more economical than biopsy and brushing when the costs of a repeated bronchoscopy including five days in day ward were above Euro 1786.
Discussion
In this study, the combination of biopsy, brushing and EBNA in one procedure was the most economical strategy for diagnosing endobronchial lesions, with an average cost of Euro 893 compared to Euro 970 for biopsy and brushing and Euro 999 for biopsy alone.
The main strength of this study was the application of an analysis that involved costs in the comparison of different diagnostic yields. The results and the threshold values should be comparable to other institutions.
There are some methodological issues to consider. Firstly, all sampling techniques were applied simultaneously in only 43 of 162 cases. The choice of combinations of sampling techniques was left to the investigator. If it was Secondly, the sample size of this study was too small to allow adjustment for the size of the lesion or the location.
Thirdly, in prospective studies it would be possible to collect data about all costs for each patient. In a retrospective study such as this, the costs must be based on a model with average costs for each procedure, which is less precise.
In this study the model for costs was based on registration of the time consumption for different health workers in the bronchoscopy lab and in the department of pathology. The time consumption is not constant and the variation was only included in the assumption that the costs were in a range of a 30% deviation. The time consumption in the cytopathology lab was based on expert opinion, prone to information bias. These assumptions and uncertainties of costs must be considered, especially when comparing to costs reported in other studies.
EBNA is the most costly sampling technique. However, prolonging the stay at the day ward and having a new procedure performed is much more costly. Thus, adding EBNA to all procedures seems warranted from the modeling in this study, since this prevented a large enough number of repeated procedures to be less costly overall. Whether this would be true for other centers will depend upon the local diagnostic yield for each procedure, and the organization of the diagnostic work-flow until conclusion.
The effectiveness of different combinations of sampling techniques has been an issue in previous studies. 4e16 In the current study, the combination of biopsy and brushing was more economical than biopsy alone given that the diagnostic yield for the combination was at least 78.0% compared to the diagnostic yield of biopsy alone of 75.8%. Previous studies have reported that brushing increased sensitivity for cancer above 2.2% compared to biopsy alone. 5, 8, 11, 14, 15, 22, 23 Compared to the diagnostic yield of biopsy and brushing of 78.8%, the combination of biopsy, brushing and EBNA was most economical in the current study if the diagnostic yield was above 84.0%. Few previous studies have included EBNA in the analyses. Three studies reported increased sensitivity for EBNA above 5.2% compared to biopsy and brushing. Given the diagnostic yields in the current study, the cost of brushing had to be below Euro 83, if biopsy and brushing should be more economical than biopsy alone. One previous study had a price of brushing below this threshold value, 12 while in the other study the price of brushing was above this threshold value. 11 The cost of EBNA had to be below Euro 205, for the combination of biopsy, brushing and EBNA to be more economical than biopsy and brushing. Only one study included EBNA; with a price below the threshold value. 12 Although the current study recommends biopsy, brushing and EBNA in one procedure, the results must be interpreted cautiously. Some institutions investigate the patients as outpatients to a much larger degree than ours. If the cost of a repeated bronchoscopy including the cost of the delay is below Euro 1786, biopsy and brushing without EBNA might be a more economical choice for an outpatient investigation. In countries where the cost for the waiting time is low, biopsy alone might be most economical.
Aspiration of fluid from the entire procedure for washings did not increase the diagnostic yield regardless, and has been omitted in our hospital for the investigations of visible lesions.
For the clinical decision maker the optimal combination of sampling techniques will be based on the willingness to pay for increased diagnostic yield. A great increase may warrant the extra costs of more sampling techniques as that would save the time and cost for a new procedure. If a center knows its own diagnostic yields for the different sampling techniques, a sensitivity analysis can reveal the threshold values for when a given technique becomes economical. It is important to emphasize that the current analysis is economical in nature, and does not take into account the psychological burden of time to diagnosis. We do not advocate to prolong the investigative time to decrease costs. On the contrary, the analyses show that even though the increased diagnostic yield was small with added sampling techniques employed, it saved money due to the high cost of diagnostic delay.
For the diagnosis of lung cancer, each diagnostic center will have slightly different results. The costs will vary with different practices and models of financial support. Thus, we recommend all centers, both excellent and regular, to calculate both their diagnostic yields, and the costs of their diagnostic work-ups, and finally to publish these results.
